People channel feed – Endpoints News

People channel feed

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

2 months ago

Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout

2 months ago

Roivant brings rare disease program closer as Immunovant CEO retires

2 months ago

Exclusive: Charm Therapeutics' founder steps down as CEO, as AI biotech eyes clinic in 2026

2 months ago

Mural Oncology ends clinical development, lays off most workers

2 months ago

Recruiters say some biopharmas pause hiring as they struggle to make sense of ongoing uncertainty

2 months ago

Vaccines, obesity drugs, job cuts: Takeaways from RFK Jr.'s first network interview as HHS chief

3 months ago

Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience

3 months ago

‘This is self-inflicted’: Leerink’s David Risinger on the market shock and hits to biopharma

3 months ago

Q&A: A conversation with GLP-1 co-discoverer Jens Juul Holst on the future of incretin-based drugs

3 months ago

Q&A: David Liu talks about science under pressure, teases “disease-agnostic” gene editing

3 months ago

Relay Therapeutics does third round of layoffs in nine months, affecting about 70 employees

3 months ago

Senate confirms Dr. Oz to lead Medicare agency amid HHS overhaul

3 months ago

Q&A: John Crowley warns biotech is 'dangerously close' to breaking, as tariff threat, markets batter industry

3 months ago

Exclusive: Mikael Dolsten shares his post-Pfizer plans, including advising an AI unicorn with pharma dreams

3 months ago

Arie Belldegrun nabs two leaders for Vida Ventures amid plans for fourth fund

3 months ago

‘It’ll be a challenge’: BIO chief Crowley addresses seismic FDA overhaul

3 months ago

Q&A: Demis Hassabis talks 'turbocharging' Isomorphic with $600M, expanding into antibodies and the US

3 months ago

Firings sweep across FDA as former leaders lament the gutting of drug agency

3 months ago

Sanofi continues its bet on R&D by poaching GSK’s head of development

3 months ago

What’s next after Marks? At FDA, questions over more top exits and future vision for drug agency

3 months ago

Inspirna, which was preparing for a Phase 3 cancer trial, has folded

3 months ago

ElevateBio trims workforce by 17%

3 months ago

Covid contrarian Bhattacharya is confirmed as NIH chief, taking over at a fraught moment for federal research

3 months ago

First page Previous page 1 234 5 6 Next page Last page